167 related articles for article (PubMed ID: 8782853)
1. Inhibition of oxidation of low density lipoprotein by troglitazone.
Noguchi N; Sakai H; Kato Y; Tsuchiya J; Yamamoto Y; Niki E; Horikoshi H; Kodama T
Atherosclerosis; 1996 Jun; 123(1-2):227-34. PubMed ID: 8782853
[TBL] [Abstract][Full Text] [Related]
2. Troglitazone increases the resistance of low density lipoprotein to oxidation in healthy volunteers.
Cominacini L; Young MM; Capriati A; Garbin U; Fratta Pasini A; Campagnola M; Davoli A; Rigoni A; Contessi GB; Lo Cascio V
Diabetologia; 1997 Oct; 40(10):1211-8. PubMed ID: 9349604
[TBL] [Abstract][Full Text] [Related]
3. The new oral hypoglycemic agent, CS-045, inhibits the lipid peroxidation of human plasma low density lipoprotein in vitro.
Nagasaka Y; Kaku K; Nakamura K; Kaneko T
Biochem Pharmacol; 1995 Sep; 50(7):1109-11. PubMed ID: 7575669
[TBL] [Abstract][Full Text] [Related]
4. Effects of troglitazone on in vitro oxidation of LDL and HDL induced by copper ions and endothelial cells.
Cominacini L; Garbin U; Pastorino AM; Campagnola M; Fratta Pasini A; Davoli A; Rigoni A; Lo Cascio V
Diabetologia; 1997 Feb; 40(2):165-72. PubMed ID: 9049476
[TBL] [Abstract][Full Text] [Related]
5. Antioxidant activities of probucol against lipid peroxidations.
Gotoh N; Shimizu K; Komuro E; Tsuchiya J; Noguchi N; Niki E
Biochim Biophys Acta; 1992 Oct; 1128(2-3):147-54. PubMed ID: 1329973
[TBL] [Abstract][Full Text] [Related]
6. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation.
Neuzil J; Stocker R
J Biol Chem; 1994 Jun; 269(24):16712-9. PubMed ID: 8206992
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of LDL oxidation in vitro but not ex vivo by troglitazone.
Crawford RS; Mudaliar SR; Henry RR; Chait A
Diabetes; 1999 Apr; 48(4):783-90. PubMed ID: 10102695
[TBL] [Abstract][Full Text] [Related]
8. The role of antioxidants in the long-term glycation of low density lipoprotein and its Cu2+-catalyzed oxidation.
Sobal G; Menzel J
Free Radic Res; 2000 May; 32(5):439-49. PubMed ID: 10766412
[TBL] [Abstract][Full Text] [Related]
9. Troglitazone reduces LDL oxidation and lowers plasma E-selectin concentration in NIDDM patients.
Cominacini L; Garbin U; Fratta Pasini A; Campagnola M; Davoli A; Foot E; Sighieri G; Sironi AM; Lo Cascio V; Ferrannini E
Diabetes; 1998 Jan; 47(1):130-3. PubMed ID: 9421387
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of oxidation of low-density lipoprotein by a novel antioxidant, BO-653, prepared by theoretical design.
Noguchi N; Okimoto Y; Tsuchiya J; Cynshi O; Kodama T; Niki E
Arch Biochem Biophys; 1997 Nov; 347(1):141-7. PubMed ID: 9344475
[TBL] [Abstract][Full Text] [Related]
11. Troglitazone-binding to LDL and its glycated modifications: its role in cell-catalysed and Cu-mediated LDL-oxidation.
Sobal G; Sinzinger H; Menzel EJ
Life Sci; 2000 Jun; 67(6):695-707. PubMed ID: 12659175
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of oxidation of low density lipoprotein by vitamin E and related compounds.
Gotoh N; Noguchi N; Tsuchiya J; Morita K; Sakai H; Shimasaki H; Niki E
Free Radic Res; 1996 Feb; 24(2):123-34. PubMed ID: 8845913
[TBL] [Abstract][Full Text] [Related]
13. Antioxidant effect of ethanol toward in vitro peroxidation of human low-density lipoproteins initiated by oxygen free radicals.
Bonnefont-Rousselot D; Rouscilles A; Bizard C; Delattre J; Jore D; Gardès-Albert M
Radiat Res; 2001 Feb; 155(2):279-87. PubMed ID: 11175662
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of copper- and peroxyl radical-induced LDL lipid oxidation by ebselen: antioxidant actions in addition to hydroperoxide-reducing activity.
Lass A; Witting P; Stocker R; Esterbauer H
Biochim Biophys Acta; 1996 Sep; 1303(2):111-8. PubMed ID: 8856040
[TBL] [Abstract][Full Text] [Related]
15. Prooxidant and antioxidant properties of Trolox C, analogue of vitamin E, in oxidation of low-density lipoprotein.
Albertini R; Abuja PM
Free Radic Res; 1999 Mar; 30(3):181-8. PubMed ID: 10711788
[TBL] [Abstract][Full Text] [Related]
16. Recycling of vitamin E in human low density lipoproteins.
Kagan VE; Serbinova EA; Forte T; Scita G; Packer L
J Lipid Res; 1992 Mar; 33(3):385-97. PubMed ID: 1314881
[TBL] [Abstract][Full Text] [Related]
17. Troglitazone has a scavenging effect on reactive oxygen species.
Inoue I; Katayama S; Takahashi K; Negishi K; Miyazaki T; Sonoda M; Komoda T
Biochem Biophys Res Commun; 1997 Jun; 235(1):113-6. PubMed ID: 9196046
[TBL] [Abstract][Full Text] [Related]
18. Troglitazone inhibits long-term glycation and oxidation of low-density lipoprotein.
Sobal G; Menzel EJ; Sinzinger H
J Cardiovasc Pharmacol; 2005 Nov; 46(5):672-80. PubMed ID: 16220075
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of the oxidation of low density lipoprotein induced by free radicals.
Noguchi N; Gotoh N; Niki E
Biochim Biophys Acta; 1993 Jul; 1168(3):348-57. PubMed ID: 8323975
[TBL] [Abstract][Full Text] [Related]
20. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol.
Stocker R; Bowry VW; Frei B
Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1646-50. PubMed ID: 2000375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
